UK Earnings, Trading Statements Calendar | |
Friday, October 24 | |
Dechra Pharmaceuticals | Interim Management Statement |
Shire | Q3 Results |
Vesuvius | Interim Management Statement |
Spectris | Interim Management Statement |
TSB Banking Group | Interim Management Statement |
Monday, October 27 | |
APR Energy | Interim Management Statement |
Tuesday, October 28 | |
UBM | Interim Management Statement |
BP | Q3 Results |
Lloyds Banking Group | Interim Management Statement |
BG Group | Q3 Results |
Utilitywise | Full Year Results |
Wednesday, October 29 | |
JZ Capital Partners | Half Year Results |
Braemar Shipping Services | Half Year Results |
Stagecoach Group | Trading statement |
Next | Interim Management Statement |
Standard Life | Trading statement |
Antofagasta | Q3 Production Report |
CSR | Q3 Results |
Johnston Press | Interim Management Statement |
Tissue Regenix Group | Half Year Results |
Redefine International | Full Year Results |
Thursday, October 30 | |
Alumasc Group | Interim Management Statement |
Kazakhmys | Interim Management Statement |
Royal Dutch Shell | Q3 Results |
Barclays | Interim Management Statement |
Genel Energy | Interim Management Statement |
Afren | Interim Management Statement |
BT Group | Half Year Results |
Henderson Group | Interim Management Statement |
J Smart and Co | Full Year Results |
Smith & Nephew | Q3 Results |
Millennium & Copthorne Hotels | Q3 Results |
Aviva | Interim Management Statement |
St James's Place | Interim Management Statement |
National Express Group | Interim Management Statement |
Copyright 2014 Alliance News Limited. All Rights Reserved. | |
Tissue Regenix's losses widen as company pushes towards significant milestones
(ShareCast News) - AIM-listed regenerative medical devices company Tissue Regenix Group's saw operating losses widen at the interim stage even as its revenues nudged higher, although it did gain regulatory approval for its products in Europe and the US. For the six months ended 31 July, revenue incr
Read more